Cite
Risk-Adapted Screening Shows Superior Diagnostic Efficacy than Fecal Immunochemical Test in Colorectal Cancer Screening: Baseline Results of a Multi-Center Randomized Controlled Trial (TARGET-C)
MLA
Hai Zhou, et al. “Risk-Adapted Screening Shows Superior Diagnostic Efficacy than Fecal Immunochemical Test in Colorectal Cancer Screening: Baseline Results of a Multi-Center Randomized Controlled Trial (TARGET-C).” SSRN Electronic Journal, Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........5d59372865ccfe5436af86c54076c4dd&authtype=sso&custid=ns315887.
APA
Hai Zhou, Ming Lu, Jufang Shi, Liming Zhu, Lanwei Guo, Lingbin Du, Qiang Zhang, Hermann Brenner, Xianzhen Liao, Xiaopeng Zhang, Shuangmei Zou, Hongda Chen, Li Liu, Baoquan Wang, Juan Zhang, Yi Gao, Hong Wang, Jiansong Ren, Haifan Xiao, … Donghua Wei. (2020). Risk-Adapted Screening Shows Superior Diagnostic Efficacy than Fecal Immunochemical Test in Colorectal Cancer Screening: Baseline Results of a Multi-Center Randomized Controlled Trial (TARGET-C). SSRN Electronic Journal.
Chicago
Hai Zhou, Ming Lu, Jufang Shi, Liming Zhu, Lanwei Guo, Lingbin Du, Qiang Zhang, et al. 2020. “Risk-Adapted Screening Shows Superior Diagnostic Efficacy than Fecal Immunochemical Test in Colorectal Cancer Screening: Baseline Results of a Multi-Center Randomized Controlled Trial (TARGET-C).” SSRN Electronic Journal, January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........5d59372865ccfe5436af86c54076c4dd&authtype=sso&custid=ns315887.